injectables
Baxter expands US portfolio with new injectables
April 12, 2024Medical Communications Pharmacy, baxter, injectables, product launch
Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of five new injectable products in …
ViiV Healthcare shares interim data from phase 3 trial for injectable HIV treatment
February 21, 2024Research and Development Cabenuva, HIV, HIV/AIDS, ViiV Healthcare, clinical trial, injectables
ViiV Healthcare has announced results from an interim analysis of the phase 3 LATITUDE trial, which assessed Cabenuva (cabotegravir and …
Injectable drug market to grow to $625 billion worldwide by 2021
March 23, 2017Sales and Marketing injectable drugs, injectables
New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …
Pfizer may sell off Hospira unit for $2 billion
January 14, 2016Manufacturing and Production, Medical Communications, Sales and Marketing Hospira, Pfizer, injectables, pumps
Pfizer is reportedly considering selling Hospira’s infusion pump business for around $2 billion, having acquired the injectable drugs and infusion …
Pfizer to pay $360m for InnoPharma
July 18, 2014Sales and Marketing Pfizer, injectables, innopharma
Pfizer is to pay as much as $360 million for private pharma development company InnoPharma in a financial arrangement comprising …
Mitsubishi Tanabe recalls two million injectables
January 28, 2011Manufacturing and Production Mitsubishi, injectables, recall
Mitsubishi Tanabe Corp has said it will recall two million of its injectable medicines made at a facility in Ashikaga, …
Pfizer pays $63m for generics portfolio
January 5, 2011Sales and Marketing Akorn, Akorn-Strides, Pfizer, Strides Arcolab, generics, injectables
Pfizer has bolstered its generics portfolio, paying around $63 million for 22 drugs. The company will buy 16 Abbreviated New …
Hospira buys Orchid generic injectables business for $400m
December 18, 2009Manufacturing and Production Hospira, India, Orchid, injectables
Indian active pharmaceutical ingredient manufacturer Orchid Chemicals & Pharmaceuticals has signed a $400 million deal to sell the assets of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
